Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats

doi:10.3748/wjg.15.1821

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 15

This Article

(0)

(17555)

(48)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Original Article

World J Gastroenterol. Apr 21, 2009; 15(15): 1821-1828
Published online Apr 21, 2009. doi: 10.3748/wjg.15.1821

Full Size Figure Download Figure

Figure 1 Histopathological sections of colons from oxazolone-induced rat colitis. Panel A, C, D, and E: Twenty-one days after establishment of model; B: Day 3 after establishment of model (HE × 50). A: Negative control; B: Positive control; C: Probiotic (C. butyricum) group; D: Mesalamine group; E: Sodium butyrate group.

Citation: Zhang HQ, Ding TT, Zhao JS, Yang X, Zhang HX, Zhang JJ, Cui YL. Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats. World J Gastroenterol 2009; 15(15): 1821-1828
URL: https://www.wjgnet.com/1007-9327/full/v15/i15/1821.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1821

Zhang HQ, Ding TT, Zhao JS, Yang X, Zhang HX, Zhang JJ, Cui YL. Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats. World J Gastroenterol 2009; 15(15): 1821-1828 [PMID: 19370778 DOI: 10.3748/wjg.15.1821]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.